BCL2 and neoplasm: The pro-apoptotic BCL-2 family member BMF39 was mutated in 4 UCEC patients (0.76%) of which 3 were low-burden tumours with nonsense mutations, similarly suggestive of a tumour suppressor role (Supplementary Fig. 11).